Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Personality factors associated with methadone maintenance dose.

Murray H, McHugh RK, Behar E, Pratt E, Otto M.

Am J Drug Alcohol Abuse. 2008;34(5):634-41. doi: 10.1080/00952990802308163.

PMID:
18821457
2.

[Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].

Trémeau F, Darreye A, Leroy B, Renckly V, Ertlé S, Weibel H, Khidichian F, Macher JP.

Encephale. 2003 Jul-Aug;29(4 Pt 1):285-92. French.

PMID:
14615698
3.

Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.

Judson G, Bird R, O'Connor P, Bevin T, Loan R, Schroder M, McGrath R, Weatherall M, Moriarty H, Robinson G.

Drug Alcohol Rev. 2010 Jan;29(1):41-6. doi: 10.1111/j.1465-3362.2009.00080.x.

PMID:
20078681
4.

High dose versus moderate dose methadone maintenance: is there a better outcome?

Fareed A, Casarella J, Roberts M, Sleboda M, Amar R, Vayalapalli S, Drexler K.

J Addict Dis. 2009 Oct;28(4):399-405. doi: 10.1080/10550880903183042.

PMID:
20155609
5.

[Evaluation of methadone dispensing in Belgium--study synopsis].

Ledoux Y.

J Pharm Belg. 2004;59(3):69-79. Review. French. No abstract available.

PMID:
15553322
6.

Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.

Loeber S, Kniest A, Diehl A, Mann K, Croissant B.

Am J Drug Alcohol Abuse. 2008;34(5):584-93. doi: 10.1080/00952990802308239.

PMID:
18720267
7.

Physicians practicing in methadone treatment programs: who are they and what do they do?

Wechsberg WM, Flannery B, Kasten JJ, Suerken C, Dunlap L, Roussel AE, Crum L, Murdoch O, Diesenhaus H.

J Addict Dis. 2004;23(2):15-31.

PMID:
15132340
8.

Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.

Winstock AR, Lea T, Sheridan J.

Int J Drug Policy. 2008 Dec;19(6):450-8. doi: 10.1016/j.drugpo.2007.03.002. Epub 2008 Mar 21.

PMID:
18359216
9.

Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.

Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL.

Addiction. 2005 Oct;100(10):1496-509.

PMID:
16185211
10.

Prescription opioid abuse among enrollees into methadone maintenance treatment.

Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD.

Drug Alcohol Depend. 2007 Sep 6;90(1):64-71. Epub 2007 Mar 26.

PMID:
17386981
11.

High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.

Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML.

Psychopharmacology (Berl). 2002 May;161(2):202-12. Epub 2002 Mar 13.

PMID:
11981600
12.

Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.

Madden A, Lea T, Bath N, Winstock AR.

Drug Alcohol Rev. 2008 Nov;27(6):671-8. doi: 10.1080/09595230801935706.

PMID:
19378450
13.

CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.

Levran O, Peles E, Hamon S, Randesi M, Adelson M, Kreek MJ.

Addict Biol. 2013 Jul;18(4):709-16. doi: 10.1111/j.1369-1600.2011.00349.x. Epub 2011 Jul 25.

14.

Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations.

Athanasos P, Smith CS, White JM, Somogyi AA, Bochner F, Ling W.

Pain. 2006 Feb;120(3):267-75. Epub 2006 Jan 19.

PMID:
16427197
15.

Methadone dose and treatment outcome.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

Drug Alcohol Depend. 1993 Sep;33(2):105-17.

PMID:
8261875
16.

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.

Ling W, Wesson DR, Charuvastra C, Klett CJ.

Arch Gen Psychiatry. 1996 May;53(5):401-7.

PMID:
8624183
17.

The prevalence of mental and physical health disorders among older methadone patients.

Rosen D, Smith ML, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2008 Jun;16(6):488-97. doi: 10.1097/JGP.0b013e31816ff35a.

PMID:
18515693
18.

Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.

Glasper A, Gossop M, de Wet C, Reed L, Bearn J.

Pharmacology. 2008;81(2):92-6. Epub 2007 Oct 19.

PMID:
17952010
19.

High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes.

McCarthy JJ, Leamon MH, Parr MS, Anania B.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):606-10.

PMID:
16150249
20.

Dose-response effects of methadone in the treatment of opioid dependence.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

Ann Intern Med. 1993 Jul 1;119(1):23-7.

PMID:
8498759

Supplemental Content

Support Center